Announced

Completed

Soleus Capital led a $50m Series C funding round in Parse Biosciences.

Synopsis

Soleus Capital, a private equity company, led a $50m Series C funding round in Parse Biosciences, a Seattle biotech startup developing single-cell sequencing products, with participation from Bioeconomy Capital, Janus Henderson Investors, Marshall Wace, Sahsen Ventures, and Saras Capital. “Customer response to our products has been extraordinary, with researchers around the world leveraging our technology to make significant scientific advances. The resounding support from investors will further our mission to make scalable single cell projects routine. We're especially excited to continue supporting many of the large-scale programs happening within biopharma,” Alex Rosenberg, Parse Biosciences CEO and Co-Founder.

Show Details & Financials

Did you work on this deal?

Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.

Sort

By continuing, you agree to our Terms & Conditions and our Data Privacy Policy

All rights reserved. Copyright © 2025 Datasite